Skip to content

SCHEDULE 13GAccepted Jun 26, 4:05 PM ET

Viridian Therapeutics, Inc.\DE SCHEDULE 13G

Paradigm Biocapital Advisors LP

Accepted (ET)

4:05 PM

Jun 26, 2026

Filed

Jun 26, 2026

Documents

2

Size

17.0 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.